RecruitingNCT05102916

Swiss Registry for Neuromuscular Disorders

Swiss Registry for Neuromuscular Disorders (Swiss-Reg-NMD)

Sponsor

University of Bern

Enrollment

2,000 participants

Start Date

Jun 20, 2018

Study Type

OBSERVATIONAL

Conditions

DMD SMA BMD IMD Congenital Muscular Dystrophy

Summary

The Swiss Patient Registry for DMD/BMD and SMA was launched in 2008 in order to give Swiss patients access to new therapies. It was founded with the financial support of several patient organizations and research foundations. Since 2008, children, adolescents and adults with DMD, BMD and SMA are registered with the help of all major muscle centers in Switzerland. After nearly ten years of activity, the Swiss Patient Registry for DMD/BMD and SMA implemented several adaptations in 2018 to meet current and future expectations of patient's organizations, health authorities and research organizations.

Eligibility

Min Age: 0 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with bmd, congenital muscular dystrophy, and other related conditions. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 0 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

Cantonal Hospital Aarau

Aarau, Canton of Aargau, Switzerland

Pediatric Institute of Southern Switzerland, Ospedale San Giovanni

Bellinzona, Canton Ticino, Switzerland

Neuro Centre of Italian Switzerland, Ospedale Regionale di Lugano

Lugano, Canton Ticino, Switzerland

University Hospital Lausanne CHUV, Children's Hospital

Lausanne, Vaude, Switzerland

University Hospital Lausanne CHUV

Lausanne, Vaude, Switzerland

University Children's Hospital Basel

Basel, Switzerland

University Hospital Basel

Basel, Switzerland

Inselspital Bern, Children's Hospital

Bern, Switzerland

Inselspital Bern

Bern, Switzerland

Institute of Social and Preventive Medicine (ISPM), University of Bern

Bern, Switzerland

University Hospitals of Geneva, Children's Hospital

Geneva, Switzerland

University Hospitals of Geneva

Geneva, Switzerland

Cantonal Hospital of Lucerne LUKS

Lucerne, Switzerland

Cantonal Hospital of Lucerne, LUKS

Lucerne, Switzerland

Private Practice Alpenquai

Lucerne, Switzerland

Cantonal Hospital of Eastern Switzerland

Sankt Gallen, Switzerland

Children's Hospital of Eastern Switzerland

Sankt Gallen, Switzerland

University Hospital Zuerich, Children's Hospital

Zurich, Switzerland

University Hospital Zuerich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05102916

Related Trials

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

NCT0728718921 locations

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

NCT076084321 location

Vasodilator and Exercise Study for DMD (VASO-REx)

NCT062907131 location

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

NCT0704714425 locations

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

NCT0599600325 locations